The global atherectomy devices market size was USD 869.75 Mn in 2022 and is likely to reach USD 2136.25 Mn by 2031, expanding at a CAGR of 10.6% during 2023–2031. The market growth is attributed to the rising geriatric population and the increasing prevalence of coronary artery disease (CAD) and peripheral artery disease (PAD).
The atherectomy procedure makes the artery wider; thus, blood can flow freely to the heart muscles. Atherectomy devices are used to remove plaque from an atherosclerotic vessel. In 1981, biomedical engineer David Auth developed an atherectomy device called a Rotabator. With the help of this device, he pulverized hardened plaquefrom the coronary arteries. Rotablator is a type of catheter-based method called rotational atherectomy.
In atherosclerosis, plaque builds up inside the arteries, reducing the blood flow and making them narrow.These devices treat coronary artery disease and peripheral artery disease.These devices apply different methods to remove plaque, including grinding, cutting, or vaporizing it.Doctors suggest an atherectomy if a blockage persists after stenting and angioplasty or plaque is hard. It is a catheter-based and minimally invasive procedure.
-
In October 2021, a research study published in Elsevier Journal revealed that the consistent upgrades in percutaneous coronary intervention have driven surgeons to minimize the invasive nature of surgical revascularization techniques. Itis likely to boost the progression toward minimally invasivecardiac surgery (MICS) methods. MICS reduces intensive care and hospital stays, lessens postoperative pain, and prevents any form of sternotomy.
The market research report finds that the COVID-19 pandemic negatively impacted the market. The pandemic has had an adverse effect onthe lifestyle of the people. Government implements several rules and regulations to curb the outbreak of the pandemic. It has affected the supply chain, global economy, and transportation of goods. In addition, healthcare providers focused on treating COVID-19 patients and postponed non-emergency procedures.
Atherectomy Devices Market Dynamics
Key Trends
Rising trend of minimally invasive surgeries is anticipated to boost the market in the coming years. Invasive surgeries cause less damage to the body than open surgery.Invasive surgeries include cryotherapy, biopsy, excision, and endoscopy. These surgeriesreduce the risk of complications and require a shorter hospital stay.
Major Drivers
Growing demand for vascular devices and the prevalence of peripheral and coronary atrial diseasesare expected to fuel the market during the forecast period. Commercialization and continuous product development are projected to drive the market.
-
In November 2021, Royal Philips launched peripheral and coronary artery applications, including the Nexcimerlaser system, in Orlando, United States. This Philips Laser System provides plug-and-play simplicity for peripheral and coronary atherectomy and lead extraction procedures. This system supports lead extraction procedures.
Existing Restraints
High cost of devices, lack of skilled healthcare professionals, and stringent regulations are expected to hamper the market. As per the National Library of Medicine (NCBI), the average cost of atherectomy is USD 9300, whereas angioplasty is USD 7300. Furthermore, a study published in the Journal of the American Heart Association (AHA) revealed that atherectomy had a 37.7% restenosis rate. Thus, patients are likely to prefer other alternative treatments over atherectomy.
Emerging Opportunities
Technological advancements in atherectomy devices are likely to create lucrative opportunities for market players during the forecast period. For example, incorporatinga medical laser system in atherectomy devices has improved the safety and effectiveness of atherectomy procedures. Laser atherectomy devicesemit high-energy light to unblock arteries. It vaporizes the blockage inside the vessels, normalizing blood flow to the peripheral tissue.
Scope of the Atherectomy Devices Market Report
The market report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Atherectomy Devices Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2022
|
|
Historic Data
|
2016–2021
|
|
Forecast Period
|
2023–2031
|
|
Segmentation
|
Product (Rotational, Laser, Directional, and Orbital), End-user (Hospitals, Ascs, Research Laboratories, Surgical Centers, and Academic Institutes), and Application (Cardiovascular, Peripheral, and Neurovascular)
|
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
Medtronic; TERUMO CORPORATION; BD (C. R. Bard, Inc.); Minnetronix, Inc.; Avinger; Angio Dynamics, Inc.; RA Medical Systems Inc; B. Braun Melsungen AG; Koninklijke Philips N.V.; and Boston Scientific Corporation
|
Market Segment Insights
Product Segment Analysis
On the basis of product, the atherectomy devices market is segmented into rotational, laser, directional, and orbital. Therotational segment is anticipated to account for a major market revenue share during the forecast period. Rotational atherectomy devices navigate through the site of blockage at a speed of up to 150,000 rpm. This device is known for ‘differential cutting’ and removes calcified plaque.
The directional segment is projected to expand at a considerable CAGR during the forecast period. Directional atherectomy devices remove the blockage from coronary arteries and ease the pain.It removes all plaque morphologies, including severe calcium. It has a metal cylinder at its distal end that houses a coaxial rotating cup-shaped blade.
End-user Segment Analysis
Based on end-user, the market is divided into hospitals, research laboratories, surgical centers, and academic institutes. The hospitals segment is expected to hold a major market share in the coming years due to the rising adoption of minimally invasive procedures.
The research laboratories segment accounts for a significant market share, owing to technological advancements in atherectomy devices. The research and development activities offer affordable medical devices that address health needs. Medical device development includes testing, prototyping, product design, verification, and validation.
Application Segment Analysis
On the basis of application, the market is segregated into cardiovascular, peripheral, and neurovascular. The cardiovascular segment is anticipated to expand at a substantial CAGR during the forecast period due to the rising prevalence of peripheral artery disease, growing incidence of diabetes, and increasing aging population.
The neurovascular segment is expected to hold a significant market share, owing to the rising inactive lifestyle. An inactive lifestyle directly affects RVLM neurons' excitability and increases the risk of cardiovascular disease.
Regional Outlook
In terms of region, the global atherectomy devices market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during the forecast period, owing to healthcare professionals' increasing adoption of atherectomy systems and favorable reimbursement scenarios. The rising demand for minimally invasive devices in the region is projected to propel the market in the coming years.
The market in Europe is anticipated to expand rapidly during the forecast period, due to rising focus on patient safety and outcomes.Furthermore, increasing alcohol consumption, unhealthy eating, and sedentary lifestyles contribute to the market growth during the forecast period.
Segments
The global atherectomy devices market has been segmented on the basis of
Product
- Rotational
- Laser
- Directional
- Orbital
End-user
- Hospitals
- Research Laboratories
- Surgical Centers
- Academic Institutes
Application
- Cardiovascular
- Peripheral
- Neurovascular
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Medtronic
- TERUMO CORPORATION
- BD (C. R. Bard, Inc.)
- Minnetronix, Inc.
- Avinger
- AngioDynamics, Inc.
- RA Medical Systems Inc
- B. Braun Melsungen AG
- Koninklijke Philips N.V.
- Boston Scientific Corporation
Competitive Landscape
Key players competing in the global atherectomy devices market are Medtronic; TERUMO CORPORATION; BD (C. R. Bard, Inc.); Minnetronix, Inc.; Avinger; AngioDynamics, Inc.; RA Medical Systems Inc; B. Braun Melsungen AG; Koninklijke Philips N.V.; and Boston Scientific Corporation.Major players are actively engaged in R&D programs and aim to expand manufacturing units to expand their consumer base and increase their product portfolio.
-
In August 2022, AngioDynamics, Inc. stated that the Auryon Atherectomy System has gained 510(k) clearance for an expanded indication, including arterial thrombectomy.
-
In February 2022, One of the key players in the market, Ra Medical Systems, announced that its pivotal clinical trial focused on evaluating the effectiveness and safety of the Dabra excimer laser system reached the enrolment of 95 patients. The system is an atherectomy device developed for treating peripheral arterial disease (PAD) patients. The company reported that it received approval from the US FDA to increase the above enrolment from 100 to 125 patients.
In November 2021, Royal Philips launched Nexcimerlaser system in Orlando, United States.This device has plug-and-play simplicity for lead extraction and coronary and peripheral atherectomy procedures. It works similarly to catheters with Level I clinical data for ISR atherectomy.
Request For Customization
Enquiry Before Buying
Speak With Analyst
